US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Nolato Q2 2020: Significant sales growth and good earnings performance by the Group

· Sales increased to SEK 2,307 million (1,987) · Operating profit (EBITA) rose to SEK 269 million (233) · EBITA margin of 11.7% (11.7) · Profit after tax was SEK 207 million (180) · Diluted earnings per share increased to SEK 7.79 (6.81) · Cash flow after investment amounted to SEK 685 million (178) · Sustained strong financial position “All three of our business areas performed well in the second quarter, given the current operating climate,” said Nolato President and CEO Christer Wahlquist. “The strong sales growth and good earnings performance resulted in the quarter

Invitation to Nolato’s third-quarter webcast conference call on 23 October

Nolato AB will publish its report for the third quarter of 2019 on Wednesday 23 October 2019 at 2.00 p.m. CET. In connection with the report, Nolato will hold a webcast conference call in English at 3.00 p.m. CET the same day. Nolato will be represented by President and CEO Christer Wahlquist and CFO Per-Ola Holmström, who will present the report and answer questions. Publication of the interim report:Wednesday 23 October 2019 at 2.00 p.m. CET Webcast conference call (in English):Wednesday 23 October 2019 at 3.00 p.m. CET Information regarding telephone numbers and website

Nolato Q2 2019: Normalised inventory situation at Integrated Solutions

Nolato AB has today published its interim report for the second quarter of 2019. · Sales totalled SEK 1,987 million (2,302) · Operating profit (EBITA) was SEK 233 million (266) · EBITA margin of 11.7% (11.6) · Profit after tax was SEK 180 million (204) · Basic earnings per share totalled SEK 6.82 (7.75) · Cash flow after investments amounted to SEK 178 million (352) · Sustained strong financial position Medical Solutions sales rose to SEK 634 million (562). Adjusted for currency, sales increased by a strong 9%. Operating profit (EBITA) rose to SEK 82 million (73).

Nolato Q1 2019: Continued strong performance from Medical Solutions

Nolato AB has today published its interim report for the first three months of 2019. · Sales totalled SEK 1,656 million (2,039) · Operating profit (EBITA) amounted to SEK 175 million (SEK 264 million incl. non-recurring items of SEK 20 million) · EBITA margin of 10.6% (12.0% excl. non-recurring items) · Profit after tax was SEK 131 million (206) · Basic earnings per share totalled SEK 4.98 (7.83) · Cash flow after investments amounted to SEK 25 million (187) · Sustained strong financial position Medical Solutions sales rose to SEK 611 million (532). Adjusted for

Nolato: Invitation to webcast conference call on 8 May

Nolato AB will publish its report for the three first months 2019 on Wednesday 8 May 2019 at 1.30 p.m. CET. In connection with report, Nolato will hold a webcast conference call in English at 2.30 p.m. the same day. Nolato will be represented by President and CEO Christer Wahlquist and CFO Per-Ola Holmström, who will present the report and answer questions. Publication of the three-month report:Wednesday 8 May 2019 at 1.30 p.m. CET Webcast conference call (in English):Wednesday 8 May 2019 at 2.30 p.m. CETInformation regarding telephone numbers and website is available at

Very strong quarter for Medical Solutions

Today’s report by Nolato for the third quarter of 2018 shows a continued good performance and strong financial position. · Sales rose by 13% to SEK 1,980 million (1,749) · Operating profit (EBITA) increased to SEK 222 million (209) excl. a negative non-recurring item of SEK –17 million (0) · The EBITA margin amounted to 11.2% (11.9), excl. non-recurring items · Profit after tax was SEK 154 million (153) · Basic earnings per share increased to SEK 6.50 (5.82), excl. non-recurring items · Cash flow after investments was SEK –68 million (308) excl. a divestment, SEK –14

Very strong quarter for all business areas

Today’s report by Nolato for the second quarter of 2018 shows a continued very strong performance. · Sales increased to SEK 2,302 million (1,675) · Operating profit (EBITA) rose to SEK 266 million (178) · The EBITA margin was 11.6% (10.6) · Profit after tax was SEK 204 million (131) · Basic earnings per share increased to SEK 7.75 (4.98) · Cash flow after investments was SEK 352 million (28) · Sustained strong financial position Adjusted for currency, sales for the Group increased by a very strong 34%. Medical Solutions sales rose to SEK 562 million (498), which,

Telephone meeting Nolato’s six-month report

Nolato’s six-month report 2018 will be published Thursday 19 July at 2.30 pm CET. In a telephone meeting at 3.30 pm CET the same day CEO Christer Wahlquist and CFO Per-Ola ­Holmström comments on the report. The telephone number is +468 229090 and the code 963459. A presentation will be published on www.nolato.com/ir before the meeting. --------Questions: Eija Lindberg +46766 331872 Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within

Strong growth and increased earnings across all business areas

Today’s report by Nolato for the first quarter of 2018 shows continued very strong performance. · Sales increased to SEK 2,039 million (1,370) · Operating profit (EBITA) rose to SEK 264 million (146) incl. non‐recurring items of SEK 20 million (0) · The EBITA margin amounted to 12.9% (10.7), or 12.0% (10.7) excluding non‐recurring items · Profit after tax was SEK 206 million (108) · Basic earnings per share increased to SEK 7.83 (4.11) · Cash flow after investments was SEK 187 million (3) · Sustained strong financial position Adjusted for currency, Group sales

Very strong performance by the Group

Today’s report by Nolato for the third quarter of 2017 shows very strong performance by the Group. · Sales rose by 69% to SEK 1,749 million (1,036) · Operating profit (EBITA) doubled to SEK 209 million (104) · The EBITA margin was 11.9% (10.0) · Profit after tax was SEK 153 million (79) · Earnings per share were SEK 5.82 (3.00) · Cash flow after investments was SEK 308 million (SEK 19 million excluding acquisitions) Adjusted for currency and acquisitions, consolidated sales growth was a very strong 57%. Integrated Solutions sales amounted to SEK 819 million (343),

Very strong sales and earnings performance by the Group

Today’s report by Nolato for the first six months of 2017 shows very strong sales performance and good profitability across all business areas, particularly for Integrated Solutions. Adjusted for currency and acquisitions, Group sales growth was a strong 43% in the second quarter and 30% for the first six months. Including acquisitions, the increase in sales was 62% and 48%, respectively. Second quarter in brief: · Sales increased to SEK 1,675 million (1,037) · Operating profit (EBITA) rose to SEK 178 million (110) · The operating margin (EBITA) was 10.6% (10.6) · Profit

Telephone meeting Nolato’s six-month report

Nolato’s six-month report 2017 will be published Wednesday 19 July at 2.30 pm CET.In a telephone meeting at 3.00 pm CET the same day CEO Christer Wahlquist and CFO Per-Ola ­Holmström comments on the interim report.>> The telephone number is 08 229090 and the code 963459.A presentation will be published on www.nolato.com/ir before the meeting. Welcome!--------Questions:Eija Lindberg +46766 331872Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading

Strong performance across all business areas

Today’s report from Nolato for the first three months of 2017 shows strong performance by all business areas, resulting in growth of 17% adjusted for currency and acquisitions. Including acquisitions, sales increased by 34%. · Sales increased to SEK 1,370 million (1,022) · Operating profit (EBITA) rose to SEK 146 million (113) · The operating margin (EBITA) was 10.7% (11.1) · Profit after tax was SEK 108 million (83) · Earnings per share were SEK 4.11 (3.16) · New business area names as per press release of 20 April 2017 “Both of last year’s acquisitions have

Continued investment and solid financial position

Today’s report by Nolato for the third quarter of 2016 shows continued investment in acquisitions and capacity. · Sales totalled SEK 1,036 million (1,084) · Operating profit (EBITA) was SEK 104 million (142) · The EBITA margin was 10.0% (13.1) · Profit after tax was SEK 79 million (105) · Earnings per share were SEK 3.00 (3.99) · Swiss company Treff AG acquired after end of period  Nolato Medical’s sales increased to SEK 395 million (368), which when adjusted for currency represents an increase of 11%. Operating profit (EBITA) totalled SEK 52 million (51), with an

Improved cash flow and continued strong financial position

Today’s report by Nolato for the first half of 2016 posts a very strong performance by Nolato Medical and significant lower volumes for Nolato Telecom. • Sales totalled SEK 1,037 million (1,280)• Operating profit (EBITA) was SEK 110 million (167)• The EBITA margin was 10.6% (13.0)• Profit after tax was SEK 79 million (125)• Earnings per share were SEK 3.00 (4.75)• Cash flow after investments was SEK 61 million (–52) “Adjusted for currency, sales in the second quarter decreased by 17% compared with the year-earlier period,” noted Nolato’s President and CEO, Christer Wahlquist.

Strong performance by Nolato Medical

Today’s report by Nolato for the first three months of 2016 posts strong performance by Nolato Medical, with growth of 14% and a margin of 13.3%. • Consolidated sales totalled SEK 1,022 million (1,073)• Operating profit (EBITA) was SEK 113 million (123)• The operating margin (EBITA) was 11.1% (11.5)• Profit after tax was SEK 83 million (93)• Earnings per share were SEK 3.16 (3.54)• Cash flow after investments was SEK 30 million (104) “Adjusted for currency, sales decreased by 4% compared with the year-earlier period. The decrease was entirely within Nolato Telecom, whose

Strong earnings and margin performance

In today’s interim report for the third quarter of 2015, Nolato reports strong earnings and margin performance. · Sales totalled SEK 1,084 million (1,095) · Operating profit (EBITA) rose by 27% to SEK 142 million (112) · Strong EBITA margin of 13.1% (10.2) · Profit after tax increased to SEK 105 million (83) · Earnings per share were SEK 3.99 (3.15) · Cash flow after investments was SEK 120 million (–13) “Nolato is showing continued high profitability, with return on capital employed of 32.0 percent over the last twelve months,” said Nolato President and CEO Hans

Increased profit and strong cash flow

In today’s interim report for the first quarter of 2015, Nolato reports increased profit and strong cash flow.• Sales rose by 15% to SEK 1,073 million (932)• Operating profit (EBITA) increased to SEK 123 million (94)• Strong EBITA margin of 11.5% (10.1)• Profit after tax was SEK 93 million (67)• Earnings per share were SEK 3.54 (2.55)• Cash flow after investments was SEK 104 million (17) “Our business areas performed well and, compared with the first quarter of 2014, all of them increased both sales and profit,” said Nolato President and CEO Hans Porat. Nolato Medical’s

Strong earnings and high margin

In today’s quarterly report for the third quarter, Nolato reports operating income (EBITA) of SEK 112 million (103), and an operating margin of an impressive 10.2% (9.2). The strong margin is explained by a continued focus on efficiency improvements, a renewed product portfolio and a flexible cost structure, not least in Asia. The Group’s sales amounted to SEK 1,095 million (1,119).“Our streamlining work and profitability focus has been fruitful. Despite the slightly lower sales, the Group’s operating margin is one whole percentage point higher compared to last year. At the same time we

Strengthened margins within all business areas

In today’s interim report for the first half of the year, Nolato reports operating income (EBITA) of SEK 194 million (233), and an operating margin of an impressive 10.2% (9.6). The strong margin is explained by a continued focus on efficiency improvements, a favourable product mix as well as a flexible cost structure, not least in Asia. The Group’s sales amounted to SEK 1,897 million (2,418).“Strong profitability has been and continues to be the highest priority, and with a strong financial position we have the prerequisites for investing for the future and continue developing together

Strong margin growth

In today’s first quarter interim report, Nolato reports an operating profit (EBITA) of SEK 94 million (122), and an operating margin of 10.1% (9.7). The reason for the strong margin is advanced market positions and sustained improvements in efficiency and productivity. Group sales stood at SEK 932 million (1,254), with cash flow after investments of SEK 17 million (16).“Although sales for the quarter were clearly lower than last year, due to the expected downturn for Nolato Telecom, the Group has delivered a very strong margin. The strong margin is the result of the Group’s focus on lean

Earnings remain strong with solid return on capital

Nolato reports sustained strong earnings and a solid return on capital in its Q3 2013 interim report released today. Group sales rose by 12% to SEK 1,119 million (999), with operating profit (EBITA) up 23% to SEK 103 million (84). Earnings per share for the past 12-month period rose to SEK 11.25 (6.70).“We’re very pleased indeed that our strong performance continued in the third quarter,” says President and CEO of Nolato, Hans Porat. Sales of the Nolato Medical business area rose 8% to SEK 310 million (288), which was well in line with market growth. Operating profit (EBITA) increased to

Strong earnings and high return on capital

In today’s interim report, Nolato reports strong earnings and a high return on capital for the second quarter. Sales increased by 11% to SEK 1,164 million (1,046) and operating income (EBITA) increased by 37% to SEK 111 million (81). Earnings per share increased to SEK 2.97 (2.05) and the cash flow after investments amounted to SEK 120 million (56, excluding acquisitions).“All our three business areas have increased the operating income and show high margins, which feels very satisfying,” comments Nolato’s President and CEO Hans Porat. The Nolato Medical business area continued its

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Media